Somatropin - Pfizer
Alternative Names: Genotonorm; Genotropin; PN 180,307Latest Information Update: 05 Nov 2023
At a glance
- Originator Pfizer
- Class Growth hormones; Hormonal replacements; Obesity therapies; Recombinant proteins
- Mechanism of Action Human growth hormone replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Growth disorders; Prader-Willi syndrome; Short stature; Somatotropin deficiency; Turner's syndrome